No Data
GENDA, Tokai Tokyo Securities has initiated coverage with an "outperform" rating.
Tokai Tokyo Securities initiated coverage on Genda <9166.T> with a Bullish "outperform" rating effective from the 1st. The Target Price is set at 1,410 yen. The company's performance is expected to be driven by a non-staffed gaming corner in North America through the sale of anime merchandise. Provided by Wealth Advisor Co.
Rating information (changes in investment determination) = Mitsukoshi Isetan, GENDAX ETC.
◎Morgan Stanley MUFG Securities (three tiers: Overweight > Equal Weight > Underweight) Mitsukoshi Isetan <3099.T> --- "Overweight" → "Equal Weight", 3,200 yen → 2,200 yen ◎Tokai Tokyo Securities (three tiers: Outperform > Neutral > Underperform) GENDTA <9166.T> --- New "Outperform", 1,410 yen Shinmetrics H <6086.T> --- "Outperform" → "Neutral"
<Rating Change Observation> Upgraded to new - GENDA / Shin-Etsu Chemical, downgraded to Shinmente H, etc.
◎ New and resumed GENGDA <9166.T> - Domestic semi-large company upgraded to the highest tier in three stages. ◎ Upgrade Shin-Etsu Chemical <4063.T> - Domestic mid-sized company upgraded to the highest tier in five stages. Advantest <6857.T> - Domestic mid-sized company upgraded to the highest tier in five stages. ◎ Downgrade Mitsukoshi Isetan <3099.T> - Bank-affiliated downgraded to the middle of three stages. Symantec H <6086.T> - Domestic semi-large company downgraded to the middle of three stages. Provided by Wealth Advisor.
Stable, U.S. stocks are resilient and the buying intent continues.
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to show a solid performance. The Dow Inc average rose by 114.09 dollars (+0.28%) in the US stock market two days ago on the 28th. Expectations for tax cuts and a stable bond market supported stock prices, while uncertainties regarding tariffs and the decline of NVIDIA (NVDA) weighed on them. Yesterday, on the 29th, it increased by 300.03 dollars (+0.75%) to 40,527.62 dollars, marking a sixth consecutive rise. Treasury Secretary Yellen stated that trade negotiations are progressing.
Soleosia, Morpho and others [Emerging Markets press release]
＜190A＞The development of ChordiaCTX-177 (ONO-7018) has been discontinued. ＜2937＞ Changes have been made to some contents of the Sunkus shareholder benefits. ＜3653＞ Morpho Holdings has strengthened its capital and business alliance with Mickware, which engages in the planning, development, production, and sales of computer systems. ＜4597＞ Soleidia has started patient registration for the Phase Ib/II clinical trial of SP-05. ＜9166＞ GENDA operates "TSUTAYA" in Japan.
Key points of attention for the PTS on the 28th = SMS, Kikkoman, Sekisui House.
▽ SMS <2175.T>, Earnings Reports and Stock Buyback ▽ Kikkoman <2801.T>, Earnings Reports and Increased Dividends and Stock Buyback ▽ Sekisui Chemical <4204.T>, Earnings Reports and Revision of Financial Estimates and Stock Buyback ▽ Autech <1736.T>, Revision of Performance and Financial Estimates ▽ Kudo Construction <1764.T>, Acquisition of Stocks of Matsushita Industrial (Subsidiarization) ▽ Marudai Food <2288.T>, Revision of Performance Estimates and Special Loss Recording ▽ Core <2359.T>, Earnings Reports and Review of Medium-term Management Plan Objectives
